The life sciences sector in the north of the UK is thriving and it’s recently been given a further boost by the government’s Science Innovation Audit (SIA) award to the Northern Powerhouse in Health Research (NPiHR).
SIAs are designed to help regions map their areas of strength when it comes to research and innovation, as well as to help them uncover any areas that could give them a competitive advantage globally.
The bid for this SIA was led by the Northern Health Science Alliance (NHSA), which is made up of NHS Trusts, universities and academic health science networks across the north of England.
Dr Hakim Yadi OBE, CEO of the NHSA, explained that the region already has a “range of assets” across industry, public services and research.
However, when these are combined they “become a globally relevant hub for cutting edge health research, innovation and improved service delivery, new markets potential and business growth”.
According to the NPiHR, one of the reasons why it was awarded the SIA is because of its ability to deliver in terms of health innovation, which forms part of the government’s Life Sciences Industrial Strategy.
A delegation of professionals led by the NHSA has recently travelled to Japan to attend some important life sciences events.
This includes BioJapan, which is Asia’s biggest biosciences conference, and one where members of the delegation can make important contacts. There is a strong history of research collaboration between Japan and the UK, while the UK is the fourth largest market for life sciences investment from Japan.
With so much happening in life sciences in the north of England, this could be a good area to focus your life science sales pipeline.
